Cognition Therapeutics Inc. Gains 28.08%
Mon, Apr 04, 2022 at 05:30 PM
Cognition Therapeutics Inc. (CGTX:NASDAQ) shot up at $3.33, a gain of 28.1%. On Sat, Apr 02, 2022, CGTX:NASDAQ hit a New 2-Week Low of $2.6. The stock appeared on our News Catalysts scanner on Wed, Mar 30, 2022 at 08:03 AM in the 'INVESTOR UPDATE' category. From Mon, Mar 21, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About Cognition Therapeutics Inc. (CGTX:NASDAQ)
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative...
Top 10 Gainers:
- GBS Inc. (GBS:NASDAQ), 67.95%
- Aterian Inc. (ATER:NASDAQ), 46.78%
- Protalix BioTherapeutics, Inc. (PLX:NYSEMKT), 41.9%
- IO Biotech Inc. (IOBT:NASDAQ), 33.16%
- VirnetX Holding Corp (VHC:NYSE), 31.33%
- Dingdong (Cayman) Limited American Depositary Shares (each two representing three) (DDL:NYSE), 28.77%
- BRC Inc. Class A (BRCC:NYSE), 28.72%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 28.08%
- Twitter, Inc. (TWTR:NYSE), 27.12%
- Jumia Technologies AG (JMIA:NYSE), 24.68%